Current and Emerging Pharmacotherapies for Primary CNS Lymphoma
Primary central nervous system lymphoma (PCNSL) constitutes a rare group of extranodal non-Hodgkin's lymphoma (NHL) primarily of B cell origin. It occurs in both immuno-competent and immune-compromised patients. High dose methotrexate (HD-MTX) based chemotherapy is the standard therapy. Chemoth...
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
SAGE Publishing
2012-01-01
|
| Ráidu: | Clinical Medicine Insights: Oncology |
| Liŋkkat: | https://doi.org/10.4137/CMO.S7752 |